6855 — Ascentage Pharma International Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapMomentum Trap

Annual balance sheet for Ascentage Pharma International, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	882	1,024	1,707	1,476	1,094
Net Total Accounts Receivable
Net Total Receivables	2.53	13.4	76.5	61.5	146
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	909	1,079	1,885	1,636	1,344
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	142	477	844	649	957
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	1,205	1,731	2,940	2,830	2,500
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	202	276	361	881	934
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	315	884	1,705	2,422	2,440
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	890	847	1,235	409	60.4
Total Liabilities & Shareholders' Equity	1,205	1,731	2,940	2,830	2,500
Total Common Shares Outstanding